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making a porous hydrogel by preparing an aqueous mixture 
of an uncrosslinked polymer and a crystallizable molecule: 
casting the mixture into a vessel; allowing the cast mixture to 
dry to form an amorphous hydrogel film; seeding the cast 
mixture with a seed crystal of the crystallizable molecule: 
growing the crystallizable molecule into a crystal structure 
within the uncrosslinked polymer; crosslinking the polymer 
around the crystal structure under conditions in which the 
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1. 
DENDRITIC MACROPOROUS HYDROGELS 
PREPARED BY CRYSTAL TEMPLATING 
This application is a continuation of U.S. patent applica 
tion Ser. No. 12/919,667, filed Aug. 26, 2010 and entitled 
DENDRITIC MACROPOROUS HYDROGELS PRE 
PARED BY CRYSTAL TEMPLATING”, which claims pri 
ority to Patent Cooperation Treaty Application Serial No. 
PCT/US2009/035257, filed Feb.26, 2009 and entitled “DEN 
DRITIC MACROPOROUS HYDROGELS PREPARED BY 
CRYSTAL TEMPLATING”, which claims priority to U.S. 
Provisional Patent Application Ser. No. 61/031,651, filed 
Feb. 26, 2008. The content of each of the above applications 
is hereby incorporated by reference. 
STATEMENT OF FEDERALLY FUNDED 
RESEARCH 
This invention was made with U.S. Government support 
under Contract No. BES-021744 and BES-0500969 awarded 
by the NSF. The government has certain rights in this inven 
tion. 
BACKGROUND 
The present invention relates in general to the field of 
hydrogels, and more particularly, to dendritic macroporous 
hydrogels prepared by crystal templating. 
Without limiting the scope of the invention, its background 
is described in connection with hydrogels. Hydrogels are 
generally polymer chain networks that are water-insoluble, 
but that absorb water. Often described as being “superabsor 
bent hydrogels are able to retain up to 99% water and can be 
made from natural or synthetic polymers. Often, hydrogels 
will have a high degree of flexibility due to their high water 
content. Common uses for hydrogels include: Sustained drug 
release, as Scaffolds (e.g., in tissue engineering), as a thick 
ening agent, as a biocompatible polymer, in biosensors and 
electrodes and for tissue replacement applications. Natural 
hydrogels may be made from agarose, methylcellulose, 
hyaluronic acid (HA), and other naturally-derived polymers. 
One method for making hydrogels is a taught by U.S. Pat. 
No. 7.307,132, issued to Nestler, et al., for a method of pro 
ducing low-odor hydrogel-forming polymers. Briefly, a low 
odor hydrogel-forming acrylic acid polymer is prepared by 
preparing a polymeric hydrogel by free-radically polymeriZ 
ing a monomer composition comprising at least 50% by 
weight of acrylic acid in an aqueous polymerization medium 
and converting said hydrogel into a particulate hydrogel or 
into hydrogel-forming powder, and optionally treating the 
particulate hydrogel or said hydrogel-forming powder with a 
crosslinking Substance which, actually or latently, contain at 
least two functional groups capable of reacting with the car 
boxyl groups on the addition polymer, characterized by the 
acrylic acid used in step (a) containing less than 400 ppm of 
acetic acid and propionic acid. 
Another method is taught by U.S. Pat. No. 6,943,206, 
issued to Haraguchi for an organic/inorganic hybrid hydrogel 
and method for manufacturing. Briefly, an organic/inorganic 
hybrid hydrogel is said to have Superior homogeneity, trans 
parency, mechanical properties, and Swelling and shrinking 
properties. A dry body of the organic/inorganic hybrid hydro 
gel is obtained by removing water from said hydrogel. The 
organic/inorganic hybrid hydrogel comprises a water soluble 













homogeneously dispersed in water, and water (C), and water 
(C) is included in a three-dimensional network formed by (A) 
and (B). 
BRIEF DESCRIPTION OF THE DRAWINGS 
For a more complete understanding of the features and 
advantages of the present invention, reference is now made to 
the detailed description of the invention along with the 
accompanying figures and in which: 
FIG. 1 shows the chemical structures of biopolymers used 
in these hydrogels and a schematic of the crystal-templating 
technique; 
FIGS. 2A to 2F are polarized light (FIGS. 2A and 2D) and 
phase contrast (FIGS. 2B, 2C, 2E, and 2F) microscopy 
images of crystal templated HA hydrogel; FIG. 2A) polarized 
light microscopy image of uncrosslinked HA hydrogel-urea 
crystal composite, (FIG. 2B) phase contrast microscopy 
image of uncrosslinked HA hydrogel-urea crystal composite; 
(FIG. 2C) phase contrast microscopy image of crosslinked 
HA hydrogel after removal of the urea crystals: (FIG. 2D) 
polarized light microscopy image of uncrosslinked HA 
hydrogel-urea crystal composite; (FIG. 2E) phase contrast 
microscopy image of uncrosslinked HA hydrogel-urea crys 
tal composite; and (FIG. 2F) phase contrast microscopy 
image of crosslinked HA hydrogel after removal of the urea 
crystals; 
FIGS. 3A to 3C are high magnification images of urea 
crystals and templated HA hydrogels: (FIG. 3A) time lapse 
series of the urea crystal front captures with video Brightfield 
microscopy; (FIG. 3B) atomic force microscopy (AFM) 
image of the Surface of a rinsed urea-templated HA hydrogel 
in air; and (FIG. 3C) profile of the AFM image perpendicular 
to the orientation of the ridges: 
FIGS. 4A to 4C show the urea seed crystal technique used 
to control the morphology of crystals and pores within HA 
hydrogels: (FIG. 4A) three separate nucleation points pro 
ducing a hydrogel with three radial patterns: (FIG. 4B) line 
nucleation points producing a hydrogel with linear alignment 
of crystals; and (FIG. 4C) magnified view of FIG. 4B. Scale 
bars are 1000 mum (FIGS. 4A and 4B) and 100 mum (FIG. 
4C); 
FIGS. 5A to 5F shows the process of urea-templating 
scaled up from droplets to thick films: (FIG.5A) photograph 
of scaled-up free standing films of plain and urea-templated 
HA and alginate; (FIG. 5B) top down view of the scanning 
electron microscopy images (SEM) of crystal templated HA 
after cross-linking and rinsing: (FIG.5C) portion of the film 
curled back to expose crevices in the hydrogel created by urea 
crystals; (FIG. 5D) cross-section of the hydrogel perpendicu 
lar to the pore orientation: (FIG. 5E) parallel cross-section 
depicting the fibrillar morphology; and (FIG. 5F) magnified 
view of image of FIG. 5E; and 
FIGS. 6A to 6F depict dendritic crystal growth within 
polymer Solutions demonstrating many possible combina 
tions of crystallizable molecules and polymers. The crystals 
were imaged by polarized light (FIGS. 6A to 6E) and phase 
contrast microscopy (FIG. 6F): (FIG. 6A) urea crystal and 
alginate; (FIG. 6B) urea crystal and 4-arm-PEG acrylate: 
(FIG. 6C) urea crystal and chitosan: (FIG. 6D) potassium 
phosphate crystal and hyaluronic acid; (FIG. 6E) b-cyclodex 
trin crystal and alginate; and (FIG. 6F) magnified image of 
b-cyclodextrin crystals and alginate. Scale bars are 1000 
mum (FIGS. 6A to 6E) and 100 mum (FIG. 6F). 
DETAILED DESCRIPTION 
While the making and using of various embodiments of the 
present invention are discussed in detail below, it should be 
US 8,728,499 B2 
3 
appreciated that the present invention provides many appli 
cable inventive concepts that can be embodied in a wide 
variety of specific contexts. The specific embodiments dis 
cussed herein are merely illustrative of specific ways to make 
and use the invention and do not delimit the scope of the 
invention. 
To facilitate the understanding of this invention, a number 
of terms are defined below. Terms defined herein have mean 
ings as commonly understood by a person of ordinary skill in 
the areas relevant to the present invention. Terms such as “a”, 
“an and “the are not intended to refer to only a singular 
entity, but include the general class of which a specific 
example may be used for illustration. The terminology herein 
is used to describe specific embodiments of the invention, but 
their usage does not delimit the invention, except as outlined 
in the claims. 
The creation of macroporosity within tissue engineering 
scaffolds is important because it influences cellular infiltra 
tion, scaffold remodeling, nutrient diffusion, Vascular 
in-growth and functional integration with native tissues. The 
present inventors have developed a novel crystal-templating 
technique to fabricate hydrogels with continuous dendritic 
porous networks. No other current method is capable of cre 
ating Such scaffolds. Additional advantages of this technique 
are that it is compatible with natural biomaterials, it is fast, 
can be scaled up, and does not require any expensive equip 
ment or reagents. Crystal-templating works by growing a 
dendritic crystal template within a solution of uncrosslinked 
biopolymer, crosslinking the biopolymer around the tem 
plate, and removing the crystals by washing with water. The 
result is a macroporous hydrogel with a network of pores 
matching the shape of the crystal template. We have used urea 
crystal templates to pattern photocrosslinked HA and cal 
cium-crosslinked alginate hydrogels. The crystal-templating 
technique and the materials created by it address the chal 
lenge of fabricating materials with intricate dendritic micro 
architecture that is observed in native tissues. 
The goal of tissue engineering is to create materials that can 
replace or repair injured tissue. To that end it is desirable to 
have tissue engineered constructs that mimic the microarchi 
tecture of native tissues. An important structural feature of 
many tissues is highly branched networks of vessels and 
ducts. Examples are the bronchioles, the microvasculature, 
lymphatic vessels, the ductal networks of salivary gland, 
mammary gland, and kidney, and the dendritic trees produced 
by neurons 1-4. Such networks exhibit branching, multiple 
length scales, a directional orientation, and three-dimension 
ality. A tissue may contain multiple entwined networks; for 
example, bronchioles, arterial vessels, and venous vessels 
within the lungs. Although many techniques are available for 
creating porosity within tissue engineered constructs they fall 
short of reproducing even one such network 5. 
Briefly, current techniques available for creating porosity 
are gas-foaming, lyophilization, thermally-induced phase 
separation and porogen leaching of salts and un-crosslinked 
polymer microspheres 6-8. Soft replica molding can trans 
fer patterns from etched silicon to polymers such as poly 
(lactide-co-glycolide), however this is a two-dimensional 
technique and the stacked layers are a poor approximation of 
three-dimensional porosity 9-10. The advantages of these 
methods are that they are easy to implement and scale-up. The 
disadvantage is that they provide little control over pore mor 
phology and limited compatibility with natural materials. 
Rapid prototyping techniques permit precise control over 
pore morphology through the use of computer-aided design 
systems 11-13. Rapid prototyping is suitable for creation of 













dimensional dendritic patterns observed in native tissues. 
Although rapid prototyping techniques are compatible with 
synthetic polymers they are not as Suitable for natural mate 
rials which are water soluble and viscous. A further limitation 
is that the resolution of Such techniques is larger than the 
length scale of individual cells and neuronal processes. Scaf 
folds depicted in the literature typically have features hun 
dreds of microns in length which are too large to precisely 
guide cellular infiltration. Fabrication of three-dimensional 
multilayer constructs can be impractical because each scaf 
fold must be built layer by layer with costly equipment. 
Hydrogel scaffolds are uniquely Suited for tissue engineer 
ing applications because they more closely resemble natural 
tissues with respect to mechanical properties, porosity, and 
water content than do other materials 14. In particular, 
polysaccharides, such as hyaluronic acid (HA) and sodium 
alginate (SA) are attractive materials because they are com 
posed of the same chemical constituents as native extracellu 
lar matrix components. They also exhibit excellent biocom 
patibility and non-immunogenicity. HA has found use as a 
dermal filler, adhesion barrier, intra-articular viscosupple 
ment, vitreal Substitute, drug delivery matrix and tissue engi 
neering scaffold for cartilage, skin, adipose and Vocal cord 
15-21. Alginate has been used extensively for cell encapsu 
lation, drug delivery and tissue engineering of adipose and 
cartilage 22-24. 
In comparison to synthetic materials, these polysaccha 
rides are considerably more difficult to work with because 
they have high molecular weights, are polydisperse, organic 
insoluble, pH and temperature sensitive, and produce viscous 
Solutions even at dilute concentrations. Thus, it is a challenge 
to create tissue engineered scaffolds with biomimetic porous 
networks in HA and SA hydrogels. To address this problem 
the present invention describes a crystal-templating tech 
nique that uses in situ crystallization to carve out pores within 
biopolymer hydrogels. Salts and Small organic molecules can 
precipitate as crystalline branching networks under certain 
conditions. The similarity between such networks and the 
dendritic patterns of microvasculature and neuronal dendritic 
trees prompted us to use in situ crystallization to template 
biopolymer hydrogels with macroporous networks. SA and 
HA are both linear, unbranched, anionic, high molecular 
weight polysaccharides (their chemical structures are 
depicted in FIG. 1), however they are distinguished by their 
mode of crosslinking HA can be crosslinked by derivatization 
with methacrylate side chains and exposure to UV light and a 
photoinitiator 25. Alginate can be crosslinked by addition of 
divalent cations which crosslink adjacent guluronic acid 
blocks 24. Both modes of crosslinking are compatible with 
the crystal-templating technique of the present invention. 
Urea was chosen as the crystallite because of its high water 
solubility and propensity for extensive hydrogen bonding to 
permit interaction with biopolymer chains in Solution. 
The method described in the present invention includes 
five steps: film casting, Solvent evaporation, crystal growth, 
crosslinking, and rinsing. These steps are depicted in FIG. 1. 
Small droplets (about.2 mu.L) of biopolymer and urea were 
cast onto microscope slides. The droplets were evaporated at 
..about.50% relative humidity to produce thin hydrated films 
of about 5 mm in diameter on microscope slides. Solvent 
evaporation is required to achieve the Super-saturation con 
ditions necessary for crystallization. Evaporation also greatly 
increases the biopolymer concentration and Solution viscos 
ity. The combination of high viscosity and hydrogen bonding 
Suppresses spontaneous urea crystallization and facilitates 
Super-saturation. Urea seed crystals were deposited on the 
tips of a fine pair oftweezers and applied to the centers of each 
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HA/urea and SA/urea film. Crystal growth began immedi 
ately and produced long dendritic branches that extended 
from the center to the edge of the film. Within seconds the 
entire volume of the hydrogel films were filled with urea 
crystals. These crystals comprised the urea crystal template. 
FIG. 1 shows the chemical structures of biopolymers used 
in these hydrogels and schematic of the crystal-templating 
technique. Crystal templated hydrogels were created by cast 
ing solution of biopolymer and urea, e.g., hyaluronic acid and 
alginate. The solvent was evaporated to achieve Supersatura 
tion conditions concentrations of urea. As seen in 1 the 
biopolymer-urea droplet is added to the glass slide, followed 
by drying 2. Resulting in the application of a seed crystal to 
the center of the film nucleated crystallization as seen in 3. 
Following crystallization the biopolymer is crosslinked by 
either UV or calcium 4. A water rinse 5 removes the urea 
crystals leaving behind a macroporous hydrogel templated 6 
with the pattern of the urea crystals. 
After the completion of the crystallization the films were 
crosslinked by either UV exposure or calcium as appropriate. 
Both methods of crosslinking are rapid and accurately pre 
serve the configuration of the crystal template. After 
crosslinking the crystals were easily removed with water. The 
end products were hydrogels with dendritic macroporous 
networks. Crystal-templated HA hydrogels are shown in FIG. 
2. These thin films are easily observable by transmission light 
microscopy. Droplets containing both biopolymer and urea 
crystals (i.e., biopolymer-urea "composites') were highly 
birefringent when observed through crossed polarizers. 
These composite films exhibited a characteristic maltese 
cross pattern indicative of radial alignment. The colors of the 
composites in polarized light appeared to correspond to film 
thickness; the films were thickest at the center and thinned out 
toward the edges. After crosslinking and rinsing, the hydro 
gels lost most of their birefringence and exhibited only a faint 
white color when viewed through crossed polarizers. The 
hydrogel morphology consisted of aligned Straight “fibrils' 
that were the inverse shape of the crystal template. 
FIGS. 2A to 2F are polarized light (FIGS. 2A and 2D) and 
phase contrast (FIGS. 2B, 2C, 2E, and 2F) microscopy 
images of crystal templated HA hydrogel. FIGS. 2A to 2D are 
images of the uncrosslinked hydrogel-crystal composite. 
FIGS. 2E and 2F images of the hydrogels after crosslinking 
and removal of the urea crystals. Crystal growth was nucle 
ated at the center of each hydrogel and grew radially outward 
toward the edge of the hydrogel. The hydrogel-crystal com 
posites in the first column exhibit a maltese cross character 
istic of alignment. The crystal template pattern was retained 
by the hydrogel after crosslinking and rinsing. Scale bars are 
1000 mum in FIGS. 2A to 2C and 100 mum in FIGS. 2D to 
2F. 
Images of urea crystal growth were captured using video 
microscopy. FIG. 3A depicts high magnification images of a 
growing urea crystal front. FIGS. 3A to 3C are high magni 
fication images of urea crystals and templated hyaluronic acid 
hydrogels. FIG. 3A is a time lapse series of the urea crystal 
front captured with video Brightfield microscopy. Images are 
five seconds apart. Scale bar-10 .mu.m. FIG. 3B is an AFM 
image of the Surface of a rinsed urea-templated HA hydrogel 
in air. The ridges correspond to the HA hydrogel. The grooves 
between the ridges had contained urea crystals that were 
washed out. This image demonstrates that HA hydrogel was 
templated by the crystallization of urea. FIG. 3C shows a 
profile of the AFM image perpendicular to the orientation of 
the ridges. 
It was found that the crystals were thin tightly packed 













branches approached neighboring crystals the local concen 
tration of urea became depleted and branch growth was ter 
minated; therefore, the longest continuous branches were 
those that grew in the most radial direction away from the 
point of nucleation. Direct observation of crystal growth con 
firmed that the crystals grew continuously; therefore, we con 
clude that the porous network within the crystal-templated 
hydrogels is also continuous. 
Branches were not observed when urea crystals were 
grown in the absence of biopolymer which indicates the 
importance of viscosity to induction of dendritic growth. 
Such an effect has been observed by others that have exam 
ined crystal growth in the presence of polymers 26, 27. We 
found that the growth rate was highly dependent on the ratio 
of urea to HA concentrations. This ratio was adjusted by 
fixing the HA concentration at 10 mg/mL and varying the 
urea concentration from 2.5 to 180 mg/mL. Crystal growth 
could not be nucleated for a ratio of 0.25. For increasing 
ratios, the growth rate also increased and reached a rate of 
1000 .mu.m/sec for a ratio of 6. For ratios of 8 and greater a 
viscous liquid was expelled from the crystals shortly after 
crystallization. This liquid was easily visible underpolarized 
light as dark liquid on the Surface of the birefringent urea 
crystals. The liquid was likely rich in HA and photoinitiator 
which are impurities with respect to urea crystals. At higher 
ratios the urea crystals became increasingly more tightly 
packed and less branched. Bulk polyhedral urea crystals were 
observed on the surface of the needle crystals when the ratio 
was 18. We concluded that ratios of 6 and under were most 
effective attemplating the biopolymer because this ensured 
that the hydrogel was templated by the crystals rather than 
excluded from the template. 
The micro-topography of a rinsed urea-templated HA 
hydrogel was observed by contact mode AFM in air (FIG. 
3B). The surface of the hydrogel consisted of alternating 
parallel valleys and ridges. The valleys were carved out by the 
growth of urea crystals. During crystallization, the crystal 
front expels the biopolymeras an impurity. Thus, the biopoly 
mer was compressed into the interstices between urea crystals 
and formed the radially aligned thin ridges. A profile of the 
hydrogel perpendicular to the length of the ridges is shown in 
FIG.3C. The dimensions of these ridges, less than 1 mum in 
height and spaced between 1 and 2.mu.m apart, are consistent 
with our observations under the light microscope in FIG.3A. 
Urea crystal growth can be nucleated two ways. Spontane 
ous nucleation occurs when the concentration of urea exceeds 
a critical Super-saturation. Typically, spontaneous nucleation 
occurred on the edges of the hydrogels. Hydrogels never had 
more than one spontaneous nucleation event because crystal 
growth was very rapid. 
FIGS. 4A to 4C show that the urea seed crystal technique 
can be used to control the morphology of crystals and pores 
within HA hydrogels. FIG. 4A shows three separate nucle 
ation points produced a hydrogel with three radial patterns. 
FIG. 4B shows a line of nucleation points produced a hydro 
gel with linear alignment of crystals. FIG. 4C shows a mag 
nified image of FIG. 4B. Scale bars are 1000 mum (FIG. 4A 
and FIG. 4B) and 100 mum (FIG. 4C). 
Applying a seed crystal to initiate urea crystal growth was 
a simple method for controlling the macro-morphology struc 
ture of the crystal template. This was done in conditions that 
Suppressed spontaneous nucleation by partially drying the 
hydrogel droplets under humid conditions. At equilibrium 
under humid conditions the hydrated films have a concentra 
tion ofurea great enough to Sustain crystal growth but too low 
for spontaneous nucleation. Un-nucleated hydrogel films 
could be maintained for days until the introduction of a seed 
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crystal. This permits selection of both the time and location of 
the nucleation. Films produced by the application of one seed 
in the center of the film are depicted in FIG. 2. Application of 
three seeds produced the three domain template in FIG. 4A. 
Individual seeds produced radial crystal growth, whereas a 
line of seeds produced parallel alignment throughout the 
hydrogel film (FIG. 4B). Thus, seed nucleation is a simple 
method for engineering template morphology. 
The droplets deposited on microscope slides formed thin 
films a few microns thick as estimated by electron micros 
copy. Crosslinked films could be released from the surfaces of 
the microscope slides by agitation and transferred to Solution 
for storage if desired. These films remained intact and did not 
fall apart, but could be enzymmatically degraded by hyalu 
ronidase and dissolved by treatment with a calcium chelator, 
EDTA. Scale-up of the urea-templating procedure was 
accomplished for both HA and SA using a procedure similar 
to that used for the droplets. The scaled-up films were pre 
pared by casting 2.6 mL of solution into 12-well plates with 
diameters of 2.2 cm per well. Three to four days were required 
to evaporate solvent. Crystal growth could be nucleated both 
spontaneously and by seed crystal. 
FIGS. 5A to 5F shows the process of urea-templating was 
scaled up from droplets to thick films. FIG. 5A is a photo 
graph of scaled-up freestanding films of plain and urea-tem 
plated HA and alginate. FIGS. 5B to 5E are SEM images of 
crystal templated HA after crosslinking and rinsing. FIG. 5B 
is a top down view. HA hydrogel was sculpted into a “fibrous 
morphology. In FIG. 5C, this portion of the film was curled 
back to expose the crevices in the hydrogel that had been 
created by urea crystals. FIG.5D shows a cross-section of the 
hydrogel perpendicular to the pore orientation depicting that 
the pores are present throughout the thickness of the hydro 
gel. FIG. 5E is a parallel cross-section depicting the fibrillar 
morphology. FIG.5F is a magnified view of FIG. 5E. 
Crystal-templated films were opaque white and had a 
fibrillar morphology observable even by eye (FIG. 5A). In 
contrast, non-templated films of HA were transparent and 
featureless. Non-templated SA films were a light milky white 
and had a fine granular morphology when viewed under phase 
contrast microscopy. All templated and non-templated HA 
and SA films were durable, pliable and easy to handle in both 
dry and Swollen conditions. 
Scaled-up templated films were too thick for their features 
to be observed by optical microscopy; therefore, the morphol 
ogy of these films was investigated by SEM. Dehydration of 
Swollen hydrogel specimens can easily create artifacts in the 
hydrogel structure and particularly on the Surface. To mini 
mize such artifacts the SEM specimens were extensively 
soaked and rinsed with methanol rather than water to remove 
urea. Urea is highly soluble in methanol (about. 160 mg/mL) 
and the templated hydrogel swelled minimally. The urea crys 
tals had been so tightly packed that the templated HA hydro 
gel had a fibrillar appearance. When observed from the top 
down a repeating “arrowhead fibrillar morphology of the 
film was clearly revealed (FIG. 5B). A curled portion of the 
film viewed at an angle revealed the interior crevices among 
the fibers that had contained the crystal template (FIG.5C). 
Cross-sections of the film perpendicular and parallel to the 
fiber orientation are depicted in FIGS. 5D and 5E, respec 
tively. These cross-sections demonstrate that the pore and 
fiber morphology was present throughout the thickness of the 
film and not confined to the Surfaces; thus, confirming that the 
templates are three-dimensional. 
The crystal-templating technique is different from existing 
technology because the crystals are grown within the hydro 














then radiates outwards filling the entire three dimensional 
Volume. This process of growth ensures that the resulting 
pores are interconnected and oriented. Importantly, the crys 
tals are Suspended within the viscous biopolymer Solution 
permitting crystal growth in three dimensions. Scale-up can 
be achieved because crystallization occurs rapidly over large 
distances. Crystallization of urea within HA and SA hydro 
gels was both easily reproducible and highly robust with 
respect to the concentrations of urea and biopolymer. This 
robustness to concentration permitted the hydrogels to be 
scaled from droplets to large films. The formation of the 
crystal templates was, however, sensitive to ambient humidity 
which affected the rate of solvent evaporation and the final 
water content of the evaporated, equilibrated hydrogel films. 
This sensitivity was circumvented through the use of con 
trolled humidity conditions. Although crystal-templating 
lacks precise control over the final pore morphology this can 
be alleviated through temporal and spatial control of the 
nucleation event through the use of seed nucleation. 
In addition to hyaluronic acid and alginate poly(ethylene 
glycol) acrylate hydrogels are also patternable by urea crys 
tallization. Exploration of other crystallites and crystal 
growth conditions will yield a range of template morpholo 
gies. For example, engineered potassium phosphate tem 
plates were determined that possess dendritic structures that 
are much larger and thicker than the urea templates. Crystal 
engineering is a set of techniques that tailors the Supramo 
lecular assembly of crystalline materials by manipulating 
crystal growth conditions. Important parameters are the con 
centrations and ratios of biopolymer and urea, Solution vis 
cosity, pH, and temperature. Additives Such as Surfactants and 
chiral molecules can selectively adhere to crystal faces and 
thereby control the branching, size and chirality of the result 
ing crystal structures 28. Such techniques may be able to 
refine the crystal structures and to produce a wide selection of 
crystal templates. 
The applications of crystal-templated hydrogels extend 
beyond tissue engineering because these hydrogels present a 
unique platform for the creation of composite materials. For 
example, infusion of the pores with cell adhesive proteins 
would be ideal for tissue engineering scaffolds. Polymeriza 
tion reactions and biomineralization within the pores can 
yield novel composites in which one component is distributed 
throughout the other component in oriented dendritic micron 
sized pores. 
Sodium hyaluronate from Streptococcus equi of molecular 
weight 1.6.times. 10. Sup.6 Da as indicated by Supplier and 
low viscosity alginic acid from brown algae were obtained 
from Sigma-Aldrich (St. Louis, Mo.). Tetra-functional poly 
(ethylene glycol) acrylate (PEG4A, MW=10 kDa) was 
obtained from Sun Bio. Photoinitiator, Irgacure 2959, was 
obtained from Ciba Specialty Chemicals (Basel, Switzer 
land). Photopolymerizations were initiated by a longwave 
UV lamp filtered around 365 nm and with an intensity of 22 
mW/cm2 (Blak-Ray B-100A, UVP. Upland, Calif.). 
Photocrosslinkable HA was prepared by our standard pro 
cedure of derivatization of HA with glycidyl methacrylate to 
yield GMHA (25). Urea-templated GMHA films were pre 
pared as depicted in FIG. 1A. An aqueous solution was pre 
pared of 10 mg/mL GMHA with 40 mg/mL urea and 0.5 
mg/mL photoinitiator (Irgacure 2959) in distilled deionized 
water. Droplets of 2.mu.L. were dispensed onto a glass micro 
Scope slide. The solvent was partially evaporated overnight at 
ambient conditions or in sealed containers with about.50% 
relative humidity maintained by saturated solutions of cal 
cium nitrate. GMHA is very hygroscopic and retained 
residual moisture in equilibrium with the humid atmosphere. 
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Thus, evaporation yielded viscous hydrogel films that were 
Super-saturated with urea. After drying, urea seed crystals 
were deposited onto the tips of a fine pair of tweezers by 
scraping the tweezers against Solid urea. Then the tweezers 
were carefully touched to the center of each droplet to nucle 
ate crystallization. Similarly, a razor-blade scraped against 
urea was used to nucleate straight lines. GMHA was 
crosslinked by 1 minute of exposure to UV. The hydrogels 
were rinsed in water to remove urea. 
Templated alginate hydrogels were prepared as shown in 
FIG. 1B. Aqueous solutions of 10 mg/mL alginate with 40 
mg/mL urea were dispensed onto microscope slides and air 
dried. After crystallization the hydrogels were crosslinked by 
covering the droplet 200 mg/mL calcium chloride solution for 
one minute. Rinsing with water removed excess calcium 
chloride and urea. 
Templated PEG4A hydrogels were prepared from aqueous 
solutions of 60 mg/mL PEG4A, 40 mg/mL urea and 0.5 
mg/mL Irgacure 2959. Potassium phosphate templated 
GMHA was prepared from a solution of 20 mg/mL GMHA, 
10 mg/mL potassium dihydrogen phosphate and 0.5 mg/mL 
Irgacure 2959. These droplets were incubated in humid 
chambers equilibrated with saturated sodium chloride solu 
tions until crystal growth was complete. 
Scale-up of Crystal Templated Hydrogels. Thick crystal 
templated hydrogels were prepared under Sterile conditions 
to prevent contamination during solvent evaporation. Aque 
ous solutions were prepared as described above, filter steril 
ized (0.22 mum PVDF, Millipore), and dispensed into ster 
ile, non-tissue culture treated 12-well plates. Each well was 
2.2 cm in diameter and a volume of 2.6 mL of sterile solution 
was dispensed per well. The solvent was evaporated in a 
sterile horizontal flow hood in the dark for four days. During 
this time urea crystallization either nucleated spontaneously 
or was nucleated by the seed crystal technique. Once nucle 
ated, crystallization is rapid and therefore spontaneously 
nucleated films had only one nucleation point. GMHA films 
were crosslinked by 1 minute of UV exposure, and rinsed 
extensively with exchanges of water over several days to 
remove urea. Alginate films were crosslinked by immersion 
in 200 mg/mL calcium chloride for twenty minutes and then 
rinsed extensively with water. 
Plain GMHA films required an additional humidifying step 
after air-drying and before photocrosslinking This step was 
required because the photocrosslinking reaction was mois 
ture sensitive. It is likely necessary for water to be retained 
within the film to permit diffusion of photoinitiator and move 
ment of GMHA chains during photoexposure. Therefore, 
air-dried films were placed in a sealed container at 
..about.85% relative humidity which was achieved by equili 
bration with saturated potassium chloride solution. GMHA 
films were incubated under these conditions for four days and 
then photocrosslinked by 1 minute of exposure to UV. 
It is contemplated that any embodiment discussed in this 
specification can be implemented with respect to any method, 
kit, reagent, or composition of the invention, and vice versa. 
Furthermore, compositions of the invention can be used to 
achieve methods of the invention. 
It will be understood that particular embodiments 
described herein are shown by way of illustration and not as 
limitations of the invention. The principal features of this 
invention can be employed in various embodiments without 
departing from the scope of the invention. Those skilled in the 
art will recognize, or be able to ascertain using no more than 













procedures described herein. Such equivalents are considered 
to be within the scope of this invention and are covered by the 
claims. 
All publications and patent applications mentioned in the 
specification are indicative of the level of skill of those skilled 
in the art to which this invention pertains. All publications and 
patent applications are herein incorporated by reference to the 
same extent as if each individual publication or patent appli 
cation was specifically and individually indicated to be incor 
porated by reference. 
The use of the word “a” or “an' when used in conjunction 
with the term “comprising in the claims and/or the specifi 
cation may mean "one.” but it is also consistent with the 
meaning of “one or more.” “at least one and “one or more 
than one.” The use of the term 'or' in the claims is used to 
mean “and/or unless explicitly indicated to refer to alterna 
tives only or the alternatives are mutually exclusive, although 
the disclosure supports a definition that refers to only alter 
natives and “and/or.” Throughout this application, the term 
“about is used to indicate that a value includes the inherent 
variation of error for the device, the method being employed 
to determine the value, or the variation that exists among the 
study Subjects. 
As used in this specification and claim(s), the words "com 
prising (and any form of comprising. Such as “comprise' and 
“comprises”), “having (and any form of having, such as 
“have” and “has'), “including (and any form of including, 
such as “includes and “include’) or “containing (and any 
form of containing, Such as “contains and “contain’) are 
inclusive or open-ended and do not exclude additional, unre 
cited elements or method steps. 
The term "or combinations thereofas used herein refers to 
all permutations and combinations of the listed items preced 
ing the term. For example, A, B, C, or combinations thereof 
is intended to include at least one of A, B, C, AB, AC, BC, or 
ABC, and if order is important in a particular context, also 
BA, CA, CB, CBA, BCA, ACB, BAC, or CAB. Continuing 
with this example, expressly included are combinations that 
contain repeats of one or more item or term, such as BB, 
AAA, MB, BBC, AAABCCCC, CBBAAA, CABABB, and 
so forth. The skilled artisan will understand that typically 
there is no limit on the number of items or terms in any 
combination, unless otherwise apparent from the context. 
All of the compositions and/or methods disclosed and 
claimed herein can be made and executed without undue 
experimentation in light of the present disclosure. While the 
compositions and methods of this invention have been 
described interms of preferred embodiments, it will be appar 
ent to those of skill in the art that variations may be applied to 
the compositions and/or methods and in the steps or in the 
sequence of steps of the method described herein without 
departing from the concept, spirit and scope of the invention. 
All Such similar Substitutes and modifications apparent to 
those skilled in the art are deemed to be within the spirit, 
Scope and concept of the invention as defined by the appended 
claims. 
While the present invention has been described with 
respect to a limited number of embodiments, those skilled in 
the art will appreciate numerous modifications and variations 
therefrom. It is intended that the appended claims cover all 
such modifications and variations as fall within the true spirit 
and scope of this present invention. 
What is claimed is: 
1. An apparatus comprising: 
a hydrogel film having first and second opposing ends; 
uncrosslinked hyaluronic acid included in the hydrogel; 
and 
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crosslinked alginate included in the hydrogel; 
wherein the alginate is crosslinked with calcium and the 
alginate is crosslinked around the uncrosslinked hyalu 
ronic acid. 
2. The apparatus of claim 1 comprising: 
a continuous pore network, connecting the first and second 
ends, including first and second pore portions parallel to 
one another; and 
a compressed fiber including a ridge compressed between 
the first and second pore portions. 
3. The apparatus of claim 2, wherein the ridges include 
compressed hyaluronic acid. 
4. The apparatus of claim 2, wherein the compressed fiber 
is included in a plurality of compressed fibers formed among 
alternating Valleys and ridges. 
5. The apparatus of claim 2, wherein the network includes 
a crystal. 
6. The apparatus of claim 1, wherein the alginate is 
crosslinked with a calcium based salt. 
7. The apparatus of claim 1, wherein the hydrogel further 
comprises at least one of a drug and a protein. 
8. The apparatus of claim 2, wherein a geometrical pattern 
for the continuous pore network is determined in response to 
a ratio of the hyaluronic acid to the alginate. 
9. The apparatus of claim 1, wherein the hyaluronic acid is 
not a derivative of hyaluronic acid. 
10. The apparatus of claim 1 included in a kit comprising a 
calcium chelator. 
11. The apparatus of claim 1, wherein the hydrogel film 
consists essentially of the uncrosslinked hyaluronic acid and 
the crosslinked alginate. 
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